Swayampakula Ramakanth

Mar 13, 2026

Swayampakula Ramakanth rated INAB as Buy on Mar 13, 2026, setting a price target of 6. Shares have remained stable near 1.89, leaving the 6 target still in play.

Mar 10, 2026

On Mar 10, 2026, ALXO was given a Buy rating by Swayampakula Ramakanth, with a target price of 4. The stock traded sideways with a -2.94% move, keeping the bullish thesis unresolved.

Mar 09, 2026

DNTH received a Buy rating from Swayampakula Ramakanth on Mar 09, 2026, aiming for 130. Price action was muted, as shares hovered around 77.86 despite the bullish outlook.

Mar 09, 2026

On Mar 09, 2026, Swayampakula Ramakanth published a Buy outlook on EVAX, with a target of 16. Shares gained 38.31%, underscoring the accuracy of the bullish outlook toward 16.

Mar 02, 2026

Swayampakula Ramakanth on Mar 02, 2026 assigned ETON a Buy rating, with a price target of 37. The recommendation remains pending validation as shares consolidate around 18.93.

Feb 27, 2026

On Feb 27, 2026, Swayampakula Ramakanth reaffirmed VCEL with a Buy rating, targeting 64. Shares slid 8.81% despite the recommendation, highlighting downside risks.

Feb 25, 2026

CORT was rated Buy by Swayampakula Ramakanth on Feb 25, 2026, with a price objective of 67. This case shows how bullish projections can fail, with the stock now below 32.15.

Jan 26, 2026

On Jan 26, 2026, Swayampakula Ramakanth initiated coverage on ECOR with a Buy rating and target of 18. The Buy call has yet to be validated as shares remain 11.86 away from the target.

Jan 26, 2026

Swayampakula Ramakanth issued a Buy recommendation for MIRM on Jan 26, 2026, price target set at 130. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 09, 2026

On Jan 09, 2026, DCTH was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 30. Investors saw limited payoff as shares fell short of the 30 target.

Jan 07, 2026

Swayampakula Ramakanth rated CGEN as Buy on Jan 07, 2026, setting a price target of 4. The call has proven timely, with shares rising 30.23% toward the price target of 4.

Dec 19, 2025

PYXS received a Buy rating from Swayampakula Ramakanth on Dec 19, 2025, aiming for 7. Momentum has favored the Buy call, with shares climbing from 1.54 to 1.54, rewarding those who trusted the recommendation.

Dec 18, 2025

On Dec 18, 2025, Swayampakula Ramakanth published a Buy outlook on ABSI, with a target of 8. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 2.39.

Dec 02, 2025

Swayampakula Ramakanth on Dec 02, 2025 assigned JANX a Buy rating, with a price target of 70. The call has struggled to gain traction, with shares losing 14.38%.

Nov 21, 2025

On Nov 21, 2025, Swayampakula Ramakanth reaffirmed MDWD with a Buy rating, targeting 36. Market indecision has kept the 36 target in a holding pattern.

Nov 19, 2025

ACTU was rated Buy by Swayampakula Ramakanth on Nov 19, 2025, with a price objective of 20. This case shows how bullish projections can fail, with the stock now below 2.56.

Nov 18, 2025

On Nov 18, 2025, Swayampakula Ramakanth initiated coverage on LFWD with a Buy rating and target of 4.5. The Buy call has yet to be validated as shares remain -2.35 away from the target.

Nov 17, 2025

Swayampakula Ramakanth issued a Buy recommendation for NUVL on Nov 17, 2025, price target set at 155. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Nov 14, 2025

Swayampakula Ramakanth rated VOR as Buy on Nov 14, 2025, setting a price target of 32. The call has proven timely, with shares rising 34.97% toward the price target of 32.

Nov 14, 2025

On Nov 14, 2025, PGEN was given a Buy rating by Swayampakula Ramakanth, with a target price of 9. Despite the Buy call, shares fell from 3.51 to 3.51, challenging the optimistic stance.

Nov 11, 2025

PSNL received a Buy rating from Swayampakula Ramakanth on Nov 11, 2025, aiming for 13. The rating hasn’t played out as hoped, with the stock trading 20.38% below expectations.

Nov 10, 2025

On Nov 10, 2025, Swayampakula Ramakanth published a Buy outlook on XFOR, with a target of 5. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 3.69.

Nov 04, 2025

Swayampakula Ramakanth on Nov 04, 2025 assigned CANF a Buy rating, with a price target of 2.5. The call has struggled to gain traction, with shares losing 97.80%.

Oct 29, 2025

On Oct 29, 2025, Swayampakula Ramakanth reaffirmed IPHA with a Buy rating, targeting 5. Shares slid 27.54% despite the recommendation, highlighting downside risks.

Oct 29, 2025

UNCY was rated Buy by Swayampakula Ramakanth on Oct 29, 2025, with a price objective of 22. A bullish response from the market helped close the gap of 15.17 to the target.

Oct 23, 2025

On Oct 23, 2025, Swayampakula Ramakanth initiated coverage on DYAI with a Buy rating and target of 3. The Buy call has yet to be validated as shares remain 2.24 away from the target.

Aug 21, 2025

Swayampakula Ramakanth issued a Buy recommendation for CLGN on Aug 21, 2025, price target set at 11. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Aug 12, 2025

Swayampakula Ramakanth rated HUMA as Buy on Aug 12, 2025, setting a price target of 3. The stock has underperformed, dropping 35.56% despite the bullish target of 3.

Jun 24, 2025

On Jun 24, 2025, OCGN was given a Buy rating by Swayampakula Ramakanth, with a target price of 7. The stock rallied 140.78% after the rating, narrowing the gap to the target of 7 and validating the bullish stance.

May 19, 2025

QSI received a Buy rating from Swayampakula Ramakanth on May 19, 2025, aiming for null. The rating hasn’t played out as hoped, with the stock trading 32.65% below expectations.

Apr 04, 2025

On Apr 04, 2025, Swayampakula Ramakanth published a Buy outlook on RNXT, with a target of 3. Market action contradicted the Buy thesis, as shares slipped to 0.8351.

Apr 02, 2025

Swayampakula Ramakanth on Apr 02, 2025 assigned MDAI a Buy rating, with a price target of 3.5. The recommendation remains pending validation as shares consolidate around 1.32.

Mar 31, 2025

On Mar 31, 2025, Swayampakula Ramakanth reaffirmed IPA with a Buy rating, targeting 5. The recommendation was supported by strong follow-through as the stock rose from 1.62 to 1.62.

Mar 28, 2025

EDAP was rated Buy by Swayampakula Ramakanth on Mar 28, 2025, with a price objective of 19. A bullish response from the market helped close the gap of 15.08 to the target.

Mar 21, 2025

Swayampakula Ramakanth issued a Buy recommendation for ELEV on Mar 21, 2025, price target set at 1. Investors following the Buy call captured upside momentum, with shares now at 0.365.

Mar 06, 2025

On Mar 06, 2025, ITOS was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 46. This case illustrates how a timely bullish rating can translate into tangible gains of 42.96%.

Feb 26, 2025

Swayampakula Ramakanth rated BCYC as Buy on Feb 26, 2025, setting a price target of 33. The stock has underperformed, dropping 57.77% despite the bullish target of 33.

Dec 10, 2024

On Dec 10, 2024, AFMD was given a Buy rating by Swayampakula Ramakanth, with a target price of 10. Despite the Buy call, shares fell from 0.1815 to 0.1815, challenging the optimistic stance.

Dec 06, 2024

MDNA received a Buy rating from Swayampakula Ramakanth on Dec 06, 2024, aiming for 2.5. Price action was muted, as shares hovered around 0.157 despite the bullish outlook.

Nov 21, 2024

On Nov 21, 2024, Swayampakula Ramakanth published a Buy outlook on INTS, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 6.78.

May 01, 2024

MDXG was rated Buy by Swayampakula Ramakanth on May 01, 2024, with a price objective of 11. This case shows how bullish projections can fail, with the stock now below 4.38.